Safety evaluation of excessive intake of peptide
- Conditions
- o
- Registration Number
- JPRN-UMIN000038963
- Lead Sponsor
- KSO Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Not provided
1. Subjects who have a history of serious illness. 2. Subjects who are under treatment with medication for lifestyle-related disease (diabetes, hypertension, dyslipidemia). 3. Subjects who have digestive tract diseases that affect digestion and absorption, and have had a history of gastrointestinal surgery (excluding appendicitis). 4. Subjects who have a medical history of serious allergy to medicine and food. 5. Subjects who are pregnant or under lactation, or who is expected to be pregnant during the study. 6. Subjects who are under treatment for or have a history of drug addiction and/or alcoholism. 7. Subjects who are planning to participate in other clinical studies. 8. Subjects who are judged unsuitable for participating in this study by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hematologic test Biochemistry test Urinalysis Blood pressure/pulse Weight/body mass index Medical interview Adverse event and side effect
- Secondary Outcome Measures
Name Time Method